Miles Duncan
Associate Director - Genotox Off-Target Discovery and Validation at Tessera Therapeutics | Cambridge, Massachusetts, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Miles Duncan serves as a Principal Scientist at Tessera Therapeutics, where he leverages his extensive expertise in next-generation sequencing (NGS), genetic medicine, and synthetic biology to drive innovative solutions in the field of genetic analysis. In his current role, Miles leads a dynamic team of five scientists focused on developing cutting-edge NGS assays that are pivotal for understanding genetic variations associated with human diseases. His leadership in establishing in-house single-cell DNA sequencing capabilities has been transformative, enabling the detection of rare single nucleotide polymorphisms (SNPs) and insertions/deletions (indels) at both on-target and off-target genomic loci. This advancement is crucial for enhancing the precision of gene editing technologies.
Miles has also played a key role in onboarding NGS assays designed to identify chromosomal translocations resulting from gene editing, a critical area of research that has significant implications for therapeutic strategies. His commitment to interdisciplinary collaboration has fostered a culture of innovation within his team, allowing for the successful execution of multiple high-impact projects. With a strong foundation in molecular cloning, immunology, and high-throughput screening, Miles is adept at integrating diverse scientific techniques to advance the understanding of genetic mechanisms underlying diseases. His exceptional communication skills and dedication to scientific excellence make him a valuable asset in the pursuit of novel treatments that can transform patient outcomes in genetic medicine. Through his work at Tessera Therapeutics, Miles Duncan continues to push the boundaries of what's possible in the realm of genetic analysis and therapeutic development.
Associate Director - Genotox Off-Target Discovery and Validation at Tessera Therapeutics in January 2025 to Present
Principal Scientist - NGS and Molecular Assays at Tessera Therapeutics in July 2022 to December 2024
Senior Scientist - NGS and Molecular Assays at Tessera Therapeutics in January 2021 to June 2022
Research Scientist in Synthetic and Molecular Biology at Sanofi in March 2019 to January 2021
Postdoctoral Fellow at Tufts University / Howard Hughes Medical Institute in October 2015 to March 2019
PhD Student at University of California, Santa Cruz in September 2010 to August 2015
Laboratory Assistant at UC Davis in April 2009 to August 2010
Features Writer at The California Aggie in January 2006 to January 2008
See more
See less
Long-read DNA Sequencing
qRT-PCR
Management
Integration Site Analysis (ISA)
PCR
Cell Culture
Molecular Biology
Western Blotting
Molecular Cloning
Biochemistry
Cell Biology
Microbiology
Flow Cytometry
Confocal Microscopy
Fluorescence Microscopy
Drug Discovery
Immunology
Tissue Culture
Microscopy
Real-Time Polymerase Chain Reaction (qPCR)
Genetics
Data Analysis
Science
Immunohistochemistry
High Throughput Screening
NGS
DNA Sequencing
Assay Development
ELISA
FACS
FlowJo
Liquid Handling
Bacterial Genetics
Interdisciplinary Collaboration
Genome Editing
Robotics
Synthetic Biology
DNA Extraction
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Biotechnology
Genomics
Aseptic Technique
Bacterial Cell Culture
Molecular Genetics
Mammalian Cell Culture
Gibson Assembly
See more
See less
Discover more about Tessera TherapeuticsWhat is Miles Duncan email address?
Email Miles Duncan at [email protected]. This email is the most updated Miles Duncan email found in 2026.
How to contact Miles Duncan?
To contact Miles Duncan send an email to [email protected]. (updated on October 30, 2024)
What company does Miles Duncan work for?
Miles Duncan works for Tessera Therapeutics
What is Miles Duncan's role at Tessera Therapeutics?
Miles Duncan is Associate Director - Genotox Off-Target Discovery and Validation
What is Miles Duncan's Phone Number?
Miles Duncan's phone (413) ***-*326
What industry does Miles Duncan work in?
Miles Duncan works in the Biotechnology Research industry.
Miles Duncan Email Addresses
Miles Duncan Phone Numbers
looking for?
Find personal and work emails for over 250M professionals.
People like Miles Duncan
Creative Consultant at Marty Raymond Creative Advertising & Copywriting
VP, Risk Manager - Payment Operations at MUFG
Founder at FabForeDev Inc
Software Engineer at Google
Vice President - Construction Division/Strategic Partnerships at Goldwater Bank N.A.
Service Supervisor at Enerflex Ltd.
Co-Founder at Scyfiant LLC
Franklin L. Burns School of Real Estate and Construction Management, Daniels College of Business at University of Denver
Client Support Specialist at Contexture
Field Director at Travelers
Advisory Services Quality and Risk, Professional Standards Manager at Grant Thornton LLP (US)
Primary at Ed Tech Consultants, LLC
Director, Iowa Caucus Project at Drake University
Independent Consultant at Marty Makinen LLC
CPA at R.A. Simasek, P.A.
Director COLI/BOLI Operations at Wilton Re
Life Sciences Marketing Manager II - Leica Biosystems at Danaher Corporation
Director of Annual Giving and Alumni Relations at Stevenson University
Senior Program Director at Physicians World/KnowledgePoint 360 Group LLC
Team Lead at Warby Parker
Show more
Show less